CClinicalTrials.gg
Sign In
WithdrawnNCT02849431MindIEUpdated Aug 25, 2016

Mindfulness for Intense Emotions: A Feasibility Trial

An interventional study of Mindfulness-based intervention in Borderline Personality Disorder, sponsored by Canterbury Christ Church University. Withdrawn at 1 site in United Kingdom. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2016-08-25.

Sponsored by Canterbury Christ Church University · Not applicable, Interventional, and Treatment

Why this study was withdrawn
Unforeseen feasibility issues arose that meant the study did not seem viable in the current form.
Phase
Not applicable
Study type
Interventional
Enrollment
0
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

This study explores the feasibility of a mindfulness-based intervention for people with a diagnosis of borderline personality disorder.

Read the detailed description

This is an uncontrolled feasibility trial of an eight-week mindfulness-based intervention for people with a diagnosis of borderline personality disorder. A battery of measures will be administered at baseline, in a time window of six to zero weeks prior to the start of the intervention. Outcome measures will be repeated in the two weeks after the end of the eight-week intervention, along with a qualitative interview.

02

Conditions studied

  • Borderline Personality Disorder

Keywords

  • mindfulness
03

In context

Personality Disorders

336 studies on the registry are indexed under Personality Disorders; 48 are open to participants now.

Browse Personality Disorders studies →

Lead sponsor

Canterbury Christ Church University is the lead sponsor of 27 studies on the registry; 6 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Are on the caseload of a United Kingdom National Health Service Assessment and Treatment Service in the recruitment area and have had contact with that service in the past three months
  • Have received the diagnosis of Borderline Personality Disorder from a suitably qualified health care professional, and continue to meet criteria for this diagnosis according to the SCID-II (Structured Clinical Interview for DSM Disorders Version II) at their screening assessment
  • Have sufficient English language speaking and comprehension abilities to access group discussions and hand-out materials
  • Have not previously engaged in a mindfulness-based intervention. As in other similar trials, a minimum dose has been operationally defined as having undertaken 50% or more of a mindfulness-based intervention delivered face-to-face by a suitably qualified health care professional
  • Are not currently receiving, nor have plans to receive any other form of psychological therapy during the course of the study

Exclusion criteria

Exclusion criteria:

  • Have psychosis
  • Misuse alcohol or drug to a level that requiring detox
  • Have a intellectual disability
  • Present a high level of risk requiring inpatient management at the time of their screening assessment
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
0 participants (actual)

Study arms

  • Experimental
    Mindfulness-based intervention

    Behavioral: Mindfulness-based intervention

Interventions

  • BehavioralMindfulness-based intervention

    A version of mindfulness-based cognitive therapy that has been adapted for people with a diagnosis of borderline personality disorder. This comprises eight weekly session, each lasting ninety minutes.

06

What researchers measure

Primary outcomes

  1. Participant retention in percent

    The number of participants who remain in the study at the post-intervention time point divided by the number of participants who are recruited into the study at baseline, expressed as a percentage

    Time frame: At post-intervention (i.e. 8 weeks after the start of the intervention).

Secondary outcomes

  1. Change from baseline at post-intervention in the Difficulties in the Emotion Regulation Scale (DERS)

    Time frame: Post-intervention (i.e. 8 weeks after the start of the intervention)

  2. Change from baseline at post-intervention in the Patient Health Questionnaire (PQH-9).

    Time frame: Post-intervention (i.e. 8 weeks after the start of the intervention)

  3. Change from baseline at post-intervention in the Generalized Anxiety Disorder Scale (GAD-7)

    Time frame: Post-intervention (i.e. 8 weeks after the start of the intervention)

  4. Change from baseline at post-intervention in the Five-Facet Mindfulness Questionnaire (FFMQ)

    Time frame: Post-intervention (i.e. 8 weeks after the start of the intervention)

  5. United Kingdom National Health Service Friends and Family Test (FFT).

    Time frame: Post-intervention (i.e. 8 weeks after the start of the intervention)

  6. Elliot et al.'s (2001) Change Interview.

    Time frame: Post-intervention (i.e. 8 weeks after the start of the intervention)

  7. Recruitment rate

    The number of participants recruited into the study at baseline divided by the time taken to recruit these participants, measured from the date at which recruitment opened.

    Time frame: Baseline

  8. Qualitative feedback from participants on intervention acceptability in response to questions 6 and 7 of Elliot et al.'s (2001) Change Interview

    Time frame: Post-intervention (i.e. 8 weeks after the start of the intervention)

07

Study locations

1 site
  • Sussex Partnership NHS Foundation Trust
    Brighton, Sussex, United Kingdom
08

References and documents

Publications

  • Elliot R. (2012). Qualitative Methods for Studying Psychotherapy Change Processes. In: Thompson, A, & Harper D. (Eds.), Qualitative research methods in mental health and psychotherapy: An introduction for students and practitioners (pp. 69-81). Chichester, UK: Wiley-Blackwells

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 25, 2016, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02849431
Lead sponsor
Canterbury Christ Church University
Collaborators
Sussex Partnership NHS Foundation Trust
Responsible party
Sponsor
First posted
Jul 29, 2016
Start date
Jul 2016
Primary completion
Aug 2016
Completion
Aug 2016
Last update
Aug 25, 2016

Study contacts

Hannah Droscher
principal investigator · Canterbury Christ Church University
Clara Strauss
study director · Sussex Partnership NHS Foundation Trust
Helen Startup
study director · Sussex Partnership NHS Foundation Trust
Fergal Jones
study director · Canterbury Christ Church University

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is withdrawn, as verified in Jul 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies in this condition

Personality Disorders→

Other studies from this sponsor

Canterbury Christ Church University

Start the discussion